Listed

ReposiTrak, Inc.: Form 10-Q for the period ended Sep 30, 2023

Filed with the SEC on Nov 14, 2023 and accepted by EDGAR at Nov 14, 2023, 22:15 ET.

Share

Management's discussion and analysis

As filed, 29,928 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Forward-Looking Statements

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements. The words or phrases “would be”, “will allow”, “intends to”, “will likely result”, “are expected to”, “will continue”, “is anticipated”, “estimate”, “project”, or similar expressions are intended to identify “forward-looking statements”. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties, including those risks factors contained in our June 30, 2023 Annual Report on Form 10-K, incorporated by reference herein. Statements made herein are as of the date of the filing of this Report with the Securities and Exchange Commission (“SEC”) and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, we do not undertake, and specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

Overview

Park City Group, Inc. DBA ReposiTrak, Inc., a Nevada corporation (“ReposiTrak”, “Park City Group”, “We”, “us”, “our” or the “Company”) is a Software-as-a-Service (“SaaS”) which operates a business-to-business (“B2B”) e-commerce, compliance & traceability, and supply chain management platform that partners with retailers, wholesalers, distributors and their product suppliers to (a) help them manage specific programs, such as out-of-stock management and scan-based trading; (b) reduce risk in their supply chain by managing compliance documents and data; ensure compliance with new regulatory requirements supporting traceability; and (c) improve product ordering and forecasting in order to accelerate sales, control risks, and improve supply chain efficiencies.

The Company’s services are grouped in three application suites:

1. **ReposiTrak Compliance Management (“***Compliance”*) solutions, which helps the Company’s customers vet suppliers and reduce a company’s potential regulatory, legal, and criminal risk from its supply chain partners by providing a way for them to ensure these suppliers are compliant with food safety regulations, such as the Food Safety Modernization Act of 2011 (“FSMA”);

2. **ReposiTrak Traceability Network (“***Traceability or RTN”*), which helps the Company’s customers comply with federal regulatory requirements of traceability and provides the lowest cost, easiest to use way to manage the capture and sharing of key data elements (KDEs) now required by Section 204d of FSMA 2011 as designated products move through the supply chain at each ‘event’ known as a ‘critical tracking event’ or “CTE”, which includes tracking from farm to shelf; and

3. **ReposiTrak Supply Chain Solutions (“***Supply Chain”*), which help the Company’s customers to more efficiently manage various interactions with their suppliers. In other words, it provides customers with greater flexibility in sourcing products by enabling them to choose new suppliers and integrate them into their supply chain faster and more cost effectively, and it helps them to manage these relationships more efficiently, enhancing revenue while lowering working capital, labor costs and reducing waste.

The Company’s services are delivered though proprietary software products designed, developed, marketed, and supported by the Company. These products provide visibility and facilitate improved business processes among all key constituents in the supply chain, starting with the retailer and moving backwards to suppliers and eventually to raw material providers.

The Company provides cloud-based applications and services that address e-commerce, supply chain, food safety, compliance, and traceability activities. The principal customers for the Company’s products are household name multi-store food retail chains and restaurants including their suppliers, branded food manufacturers, food wholesalers and distributors, and other food service businesses.

The Company has a hub and spoke business model. The Company is typically engaged by retailers and wholesalers (“Hubs”), which in turn require their suppliers (“Spokes”) to utilize the Company’s services.

The Company is incorporated in the State of Nevada and has three principal subsidiaries: PC Group, Inc., a Utah corporation (98.76% owned) (“PCG Utah”); Park City Group, Inc., a Delaware corporation (100% owned) (“PCG Delaware”); and ReposiTrak (100% owned) (PCG Utah, PCG Delaware, and ReposiTrak are, collectively, the “Subsidiaries”). All intercompany transactions and balances have been eliminated in the Company’s consolidated financial statements, which contain the operating results of the operations. The Company has no business operations separate from the operations conducted through its Subsidiaries.

The Company’s principal executive offices are located at 5282 South Commerce Drive, Suite D292, Murray, Utah 84107. Its telephone number is (435) 645-2000. Its website address is www.repositrak.com (http://www.repositrak.com).

Recent Developments

Dividend Payment

On September 19, 2023, the Company’s Board of Directors declared a quarterly cash dividend of $0.015 per share ($0.06 per year), payable to shareholders of record on September 29, 2023, which were paid to shareholders of record on or about November 1, 2023. Based on the closing prices on September 30, 2023, this represented an annual dividend yield of approximately 1.06%. Subsequent quarterly dividends will be paid within 45 days of each record date of December 31, 2023, March 31, 2024, and June 30, 2024,

Redemption and Retirement of Preferred Stock

On September 12, 2023, the Company announced its plans to commence the redemption and retirement of its Series B Convertible Preferred Stock and Series B-1 Preferred Stock (together, the “Preferred Stock”) for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”). The Preferred Redemption is to occur over the next three years from September 12, 2023. As of September 30, 2023, the Company had not redeemed or retired any Preferred Stock.

Global Pandemics, Bank Failures, and Geopolitical Conflicts

The impact of global pandemics, including COVID 19, banking failures, geopolitical conflicts, including the war in Ukraine, creates much uncertainty in the global marketplace. Management continues to monitor the ongoing impact of these events on all aspects of its business, including how they impact its services, customers, employees, vendors, and business partners now and in the future. While these events did not materially adversely affect the Company’s financial results and business operations in the year ended June 30, 2023 and the fiscal quarter ended September 30, 2023, we are unable to predict the impact that these events, including geopolitical conflicts, will have on its future financial position and operating results due to numerous uncertainties.

FSMA Section 204(d)

In 2020, the United States Food & Drug Administration (“FDA”) announced the “New Era of Smarter Food Safety” blueprint. It “outlines achievable goals to enhance traceability, improve predictive analytics, respond more rapidly to outbreaks, address new business models, reduce contamination of food, and foster the development of stronger food safety cultures.” But one particular section of the Food Safety Modernization Act (“FSMA”), Section 204(d) which has to deal with traceability, was left incomplete when the regulation was enacted in 2011. FDA has been working for the last few years to define exactly what traceability means and what is required to comply with that section of the law.

As part of the 2020 “New Era” announcement, FDA published the Food Traceability List or (“FTL”). FDA used a “risk assessment model” to identify 16 of the highest-risk categories to start with. There is not a single grocery retailer who does not sell these items. These 16 categories represent thousands of individual items and FDA has made it clear in its communications the categories on the FTL are only the beginning. FDA states that they would “encourage the voluntary adoption of these practices industry-wide,” which means more categories are expected to be added over time.

On November 7, 2022, FDA announced the final rule on FSMA Section 204(d) and proposes it would become effective 60 days after publication in the Federal Register. The proposed compliance date for all persons subject to the recordkeeping requirements would be 2 years after the effective date of the final regulation.

For traceability, FDA requires the capture, creation and sharing of specific key data elements (“KDE”) at each designated Critical Tracking Event (“CTE”) for every item and every shipment. FDA also requires the data be stored for two years and be retrievable and presented to them within 24 hours upon request. FSMA 204 is ultimately about recording all movement of inventories through the supply chain. The result is an enormous amount of data to manage. At the root, it is a supply chain data management issue, which is ReposiTrak’s core expertise. That’s why we’ve made it our goal to develop a traceability solution that’s easy, inexpensive and exceeds FDA’s requirements with the guidance of industry thought leaders gathered in the Food Traceability Leadership Consortium. As the largest connected network of food suppliers, wholesalers and retailers in the world, the ReposiTrak Traceability Network® is well positioned to provide end-to-end traceability to provide a safer food supply chain, tighten control on food waste and implement a food recall response that saves lives and money.

Results of Operations

Comparison of the Three Months Ended September 30, 2023 to the Three Months Ended September 30, 2022.

Revenue

Fiscal Quarter Ended September 30, 2023 2022 Variance Dollars Percent
Revenue $5,060,112 $4,720,477 $339,635 7%

Revenue was $5,060,112 and $4,720,477 for the three months ended September 30, 2023 and 2022, respectively, a 7% increase year-over-year. The increase in revenue was due to revenue growth in subscription, services and other recurring revenue. This is the result of growing industry and consumer concern of food contaminations and food safety hazards, whether biological, chemical, physical, or allergenic. The risks have elevated regulatory requirements, documentation requisites, and principally “where does your food come from” transparency on grocery retailers and their suppliers. As more and more retailers, wholesalers and distributors adopt the risk concerns and disclosure requirements, the Company has seen a rising demand for its services.

Although no assurances can be given, we continue to focus our sales efforts on marketing our software services on a recurring subscription basis and placing less emphasis on transactional revenue. However, we believe there will continue to be a small percentage of customers that will require buying a particular service outright (i.e., a license). We will continue to make our best effort to reduce this non-recurring transactional revenue when we are able.

Cost of Services and Product Support

Fiscal Quarter Ended September 30, 2023 2022 Variance Dollars Percent
Cost of services and product support $766,334 $832,704 $(66,370) -8%
Percent of total revenue 15% 18%

Cost of services and product support was $766,334 and $832,704 for the three months ended September 30, 2023 and 2022, respectively, an 8% decrease. This $66,370 decrease is primarily the result of decreased salary and support services resulting from the Company’s internal restructuring of managerial positions in effort to increased demand in response to the FSMA 204 initiative.

Sales and Marketing Expense

Fiscal Quarter Ended September 30, 2023 2022 Variance Dollars Percent
Sales and marketing $1,505,501 $1,200,259 $305,242 25%
Percent of total revenue 30% 25%

Sales and marketing expense were $1,505,501 and $1,200,259 for the three months ended September 30, 2023 and 2022, respectively, a 25% increase. This increase in sales and marketing expense is primarily the result of an increase in trade show expense, investment in FSMA 204 traceability marketing, and higher sales travel expense. As the pandemic continues to abate, many customers and prospects are returning to the “new normal” requiring in person meetings. The largest contributor to the increase in sales and marketing expense has been an increase in travel cost and trade shows. We believe this trend will continue as many of our trading partners and industry associations will continue to require our assistance in addressing their compliance and supply chain needs.

General and Administrative Expense

Fiscal Quarter Ended September 30, 2023 2022 Variance Dollars Percent
General and administrative $1,279,323 $1,223,462 $55,861 5%
Percent of total revenue 25% 26%

General and administrative expense was $1,279,323 and $1,223,462 for the three months ended September 30, 2023 and 2022, respectively, a 5% increase. The increase in general and administrative expense is primarily due to increased salary expense and a rise in general operating costs caused by increased inflation and overall current market conditions.

Depreciation and Amortization Expense

Fiscal Quarter Ended September 30, 2023 2022 Variance Dollars Percent
Depreciation and amortization $308,945 $236,006 $72,939 31%
Percent of total revenue 6% 5%

Depreciation and amortization expense was $308,945 and $236,006 for the three months ended September 30, 2023 and 2022, respectively, an increase of 31%. This increase is due to additional assets acquired in the prior fiscal year. Given the rising global hacks on software companies, banks, and financial institutions, we spent approximately $420,000 on security, backup, storage, and redundancy. The upgrades were financed through a leasing agent with an effective APR rate of 4.45%.

Other Income and Expense

Fiscal Quarter Ended September 30, 2023 2022 Variance Dollars Percent
Net other income (expense) $279,003 $117,072 $161,931 138%
Percent of total revenue 6% 2%

Net other income was $279,003 for the three months ended September 30, 2023, compared to net other income of $117,072 for the three months ended September 30, 2022. Other income increased due to an increase in interest income attributable to rising interest rates on fixed income instruments on excess cash.

Preferred Dividends

Fiscal Quarter Ended September 30, 2023 2022 Variance Dollars Percent
Preferred dividends $146,611 $146,611 $- -%
Percent of total revenue 3% 3%

Dividends accrued on the Company’s Series B-1 Preferred was $146,611 for the three months ended September 30, 2023 and for the three months ended September 30, 2022. Dividends remained flat in the comparable periods.

Financial Position, Liquidity and Capital Resources

We believe that our existing cash and short-term investments, together with funds generated from operations, are sufficient to fund operating and investment requirements for at least the next twelve months. Our future capital requirements will depend on many factors, including macroeconomic conditions, our rate of revenue growth, sales and marketing activities, the timing and extent of spending required for research and development efforts and the continuing market acceptance of our products and services.

As of September 30, 2023 June 30, 2023 Variance Dollars Percent
Cash and cash equivalents $23,697,228 $23,990,879 $(293,651) -1%

We have historically funded our operations with cash from operations, equity financings, and borrowings from our existing line of credit with U.S. Bank N.A. (the “Bank”), which was revised on October 6, 2021, and again in 2022.

Cash was $23,697,228 and $23,990,879 at September 30, 2023 and June 30, 2023, respectively. This 1% decrease is primarily the result of the purchase of Common Stock under our Share Repurchase Program and payment of dividends on both the Preferred Stock and Common Stock.

Net Cash Flows from Operating Activities

Three Months Ended September 30, 2023 2022 Variance Dollars Percent
Cash provided by operating activities $1,520,770 $1,811,475 $(290,705) -16%

Net cash provided by operating activities is summarized as follows:

Three Months Ended September 30, 2023 2022
Net income $1,378,548 $1,285,112
Noncash expense and income, net 484,149 511,194
Net changes in operating assets and liabilities (341,927) 15,169
$1,520,770 $1,811,475

15

Net cash provided by operating activities for the three months ended September 30, 2023 was $1,520,770 as compared to net cash provided by operating activities of $1,811,475 for the three months ended September 30, 2022. Net cash provided by operating activities decreased 16% due principally to an increase in accounts receivable and a decrease in accounts payable. Noncash expense decreased by $27,045 in the three months ended September 30, 2023, compared to three months ended September 30, 2022 as a result of a decrease in bad debt expense and stock compensation expense offset by an increase in depreciation and amortization.

Net Cash Flows from Investing Activities

Three Months Ended September 30, 2023 2022 Variance Dollars Percent
Cash used in investing activities $- $(19,533) $19,533 -100%

Net cash used in investing activities for the three months ended September 30, 2023 was $0 compared to net cash used in investing activities of $19,533 for the three months ended September 30, 2022. This decrease in cash used in investing activities for the three months ended September 30, 2023 was due to no purchases of property and equipment in the current fiscal quarter.

Net Cash Flows from Financing Activities

Three Months Ended September 30, 2023 2022 Variance Dollars Percent
Cash used in financing activities $(1,814,421) $(1,625,163) $(189,258) 12%

Net cash used in financing activities totaled $1,814,421 for the three months ended September 30, 2023, as compared to cash used in financing activities of $1,625,163 for the three months ended September 30, 2022. The increase in net cash used in financing activities is primarily attributable to the payment of Common Stock dividends and the purchase of Common Stock under the Share Repurchase Program offset by decrease in cash payments due to the payoff of our line of credit arrangement with a bank in the prior fiscal quarter.

Liquidity and Working Capital

At September 30, 2023, the Company had positive working capital of $22,917,547, as compared with positive working capital of $23,042,199 at June 30, 2023. This $124,652 decrease in working capital is primarily due to an increase in accounts receivable and decrease in prepaid and other assets offset by an increase in contract liabilities and deferred revenue. Cash and cash equivalents also decreased due to payment of quarterly Common Stock dividends announced in the prior fiscal year.

As of September 30, 2023 As of June 30, 2023 Variance Dollars Percent
Current assets $27,196,488 $27,274,620 $(78,132) -%

Current assets totaled $27,196,488 as of September 30, 2023, as compared to $27,274,620 as of June 30, 2023. The decrease in current liabilities is primarily attributable to the decrease in cash, prepaid expense and other current assets offset by an increase in accounts receivables.

As of September 30, 2023 As of June 30, 2023 Variance Change Percent
Current liabilities $4,278,941 $4,232,421 $46,520 1%
Current ratio 6.36 6.44 (0.08) -1%

Current liabilities totaled $4,278,941 as of September 30, 2023 as compared to $4,232,421 as of June 30, 2023. The increase in current liabilities is primarily attributable to the increase in contract liabilities and deferred revenue. As of September 30, 2023, the Company has zero bank debt.

On October 6, 2021, the Company and U.S. Bank N.A. (the “Bank”) executed a Revolving Credit Agreement (the "Revolving Credit Agreement”) and accompanying addendum (the "Addendum"), and Stand-Alone Revolving Note (the "Note" and collectively with the Revolving Credit Agreement and Addendum, the "Credit Agreement"), with an effective date of September 30, 2021. The Credit Agreement replaced the Company’s prior $6.0 million Revolving Credit Agreement and Stand-Alone Revolving Note between the Company and the Bank, as amended and revised on January 9, 2019, and provided the Company with a $10.0 million revolving line of credit that matured on March 31, 2023. The Credit Agreement contained customary affirmative and negative covenants and conditions to borrowing, as well as customary events of default. Among other things, the Company must maintain liquid assets equal to $12 million and maintain a Senior Funded Debt (as defined in the Credit Agreement) to EBITDA Ratio (as defined in the Credit Agreement) of not more than 3:1.

On April 28, 2023, the Company and the Bank executed an Amendment to the Credit Agreement, with an effective date of March 31, 2023. The new amendment provisions to the existing $10 million facility are (1) the Company will increase its liquidity requirement from $10 million to $12 million. Currently the Company maintains over $22 million in cash and a current ratio of over 6:1; and (2) Draws on the facility accrue interest at the annual rate equal to 1.75% plus the one-month SOFR rate instead of the previous LIBOR rate. As of September 30, 2023, the balance of the facility was zero. The Company had zero bank debt at September 30, 2023.

While no assurances can be given, management currently believes that the Company will continue to increase its cash flow from operations and working capital position in subsequent periods. The Company’s increase in anticipated cash flow from operations and working capital position is expected to be offset by the use of cash required to fund the Company’s quarterly cash dividends of $0.015 per share, announced on September 28, 2022, December 30, 2022, February 10, 2023, March 21, 2023, June 20, 2023 and September 19, 2023, as well as the redemption and retirement of the Company’s Series B Convertible Preferred Stock and Series B-1 Preferred Stock (together, the “Preferred Stock”) for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”).

The Preferred Redemption is to occur over the next three years from September 12, 2023. As of September 30, 2023, the Company had not redeemed or retired any shares of Preferred Stock. The Company believes it will have adequate cash resources to fund its operations, satisfy its debt obligations, and fund its anticipated quarterly cash dividends and Preferred Redemption for at least the next 12 months.

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenue, and results of operation, liquidity or capital expenditures.

Contractual Obligations

Total contractual obligations and commercial commitments as of September 30, 2023 are summarized in the following table:

Operating Leases Financing Leases
Less than 1 Year $73,835 $225,243
1-3 Years 154,383 82,727
3-5 Years 114,713 -
Total lease payments 342,931 307,970
Less imputed interest (35,331) (11,510)
Total $307,600 $296,460

Critical Accounting Policies

This Management’s Discussion and Analysis of Financial Condition and Results of Operations discusses the Company’s financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles.

We commenced operations in the software development and professional services business during 1990. The preparation of our financial statements requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenue and expense during the reporting period. On an ongoing basis, management evaluates its estimates and assumptions. Management bases its estimates and judgments on historical experience of operations and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Management believes the following critical accounting policies, among others, will affect its more significant judgments and estimates used in the preparation of our consolidated financial statements.

Income Taxes

In determining the carrying value of the Company’s net deferred income tax assets, the Company must assess the likelihood of sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions, to realize the benefit of these assets. If these estimates and assumptions change in the future, the Company may record a reduction in the valuation allowance, resulting in an income tax benefit in the Company’s statements of operations. Management evaluates whether to realize the deferred income tax assets and assesses the valuation allowance quarterly.

Goodwill and Other Long-Lived Asset Valuations

Goodwill and other long-lived assets assigned to specific reporting units are reviewed for possible impairment at least annually or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value. Management reviews the long-lived tangible and intangible assets for impairment when events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Management evaluates, at each balance sheet date, whether events and circumstances have occurred which indicate possible impairment. The carrying value of a long-lived asset is considered impaired when the anticipated cumulative undiscounted cash flows of the related asset or group of assets is less than the carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the estimated fair market value of the long-lived asset. Economic useful lives of long-lived assets are assessed and adjusted as circumstances dictate.

Revenue Recognition

Effective July 1, 2018, the Company adopted the Financial Accounting Standards Board’s Accounting Standards Update 2014-09: Revenue from Contracts with Customers (Topic 606), and its related amendments (“ASU 2014-09”). ASU 2014-09 provides a unified model to determine when and how revenue is recognized and enhances certain disclosure around the nature, timing, amount and uncertainty of revenue and cash flows arising from customers.

ASU 2014-09 represents a change in the accounting model utilized for the recognition of revenue and certain expense arising from contracts with customers. The Company adopted ASU 2014-09 using a “modified retrospective” approach and, accordingly, revenue and expense totals for all periods before July 1, 2018 reflect those previously reported under the prior accounting model and have not been restated.

See Note 2 to our Unaudited Consolidated Financial Statements included in Part I, Item 1 of this Report for a full description of the impact of the adoption of new accounting standards on our financial statements. Following the adoption of this guidance, the revenue recognition for our sales arrangements remained materially consistent with our historical practice and there have been no material changes to our critical accounting policies and estimates as compared to our critical accounting policies and estimates included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023.

Share-Based Compensation

The Company accounts for its share-based compensation to employees and non-employees in accordance with FASB ASC 718, Compensation – Stock Compensation. Stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense over the requisite service or vesting period.

Leases

Effective July 1, 2019, the Company adopted the requirements of Accounting Standards Update No. 2016-02, "Leases (Topic 842)" ("ASU 2016-02"). All amounts and disclosures set forth in this Report have been updated to comply with this new standard with results for reporting periods beginning after July 1, 2019 presented under ASU 2016-02, while prior period amounts and disclosures are not adjusted and continue to be reported under the accounting standards in effect for the prior period.

Market risk

As filed, 2,083 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our business is conducted principally in the United States. As a result, our financial results are not affected by factors such as changes in foreign currency exchange rates or economic conditions in foreign markets. We do not engage in hedging transactions to reduce our exposure to changes in currency exchange rates, although if the geographical scope of our business broadens, we may do so in the future.

Our exposure to risk for changes in interest rates relates primarily to our investments in short-term financial instruments. Investments in both fixed rate and floating rate interest earning instruments carry some interest rate risk. The fair value of fixed rate securities may fall due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Partly as a result of this, our future interest income may fall short of expectations due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that have fallen in estimated fair value due to changes in interest rates. However, as substantially all of our cash consist of bank deposits and short-term money market instruments, we do not expect any material change with respect to our net income as a result of an interest rate change.

Our exposure to interest rate changes related to borrowing has been limited, and we believe the effect, if any, of near-term changes in interest rates on our financial position, results of operations and cash flows should not be material. At September 30, 2023, our debt portfolio was composed of (1) Bank Line of Credit – SOFR + 1.75%. The balance is zero. (2) Leases – Effective APR Fixed is 4.55%. Total lease obligations are on a three-year straight-line basis. The total cost is less than $400,000.

The table that follows presents fair values of principal amounts and weighted average interest rates for our investment portfolio as of September 30, 2023:

Cash: Aggregate Fair Value Weighted Average Interest Rate
Cash $23,697,228 4.93%

Controls and procedures

As filed, 1,609 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of disclosure controls and procedures. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, an evaluation of the effectiveness of the design and operations of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of September 30, 2023 was completed. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer believe that our disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, including to ensure that information required to be disclosed by the Company is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in internal controls over financial reporting. The Company’s Chief Executive Officer and Chief Financial Officer have determined that there have been no changes in the Company’s internal control over financial reporting during the period covered by this report identified in connection with the evaluation described in the above paragraph that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II

OTHER INFORMATION

Risk factors

As filed, 214 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There are no risk factors identified by the Company in addition to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-07-01 to 2023-09-30$5.1mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue3 months2023-07-01 to 2023-09-30$766.3kus-gaap:CostOfGoodsAndServicesSold
Operating income3 months2023-07-01 to 2023-09-30$1.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2023-07-01 to 2023-09-30$6.3kus-gaap:InterestExpense
Income tax3 months2023-07-01 to 2023-09-30$100.5kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-07-01 to 2023-09-30$1.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-07-01 to 2023-09-30$0.07us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-07-01 to 2023-09-30$0.07us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-07-01 to 2023-09-3018,839,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2023-07-01 to 2023-09-30$1.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2023-07-01 to 2023-09-30$0us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2023-07-01 to 2023-09-30$421.2kus-gaap:PaymentsOfDividends
Share repurchases3 months2023-07-01 to 2023-09-30$1.3mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2023-09-30$23.7mus-gaap:Cash
Current assetsAt period end2023-09-30$27.2mus-gaap:AssetsCurrent
Total assetsAt period end2023-09-30$50.2mus-gaap:Assets
Current liabilitiesAt period end2023-09-30$4.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-09-30$4.6mus-gaap:Liabilities
Shareholders' equityAt period end2023-09-30$45.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-23-032047. Last ingested by Listed: Oct 24, 2026, 14:53 ET. Listed shows no prices and gives no investment advice.